BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17487649)

  • 1. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Taechakraichana N; Holinka CF; Haines CJ; Subramaniam R; Tian XW; Ausmanas MK
    Climacteric; 2007 Jun; 10(3):225-37. PubMed ID: 17487649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in levels of bone and cartilage biomarkers and hormonal responsiveness in nine groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Holinka CF; Christiansen C; Tian XW; Ausmanas MK
    Climacteric; 2008 Feb; 11(1):44-54. PubMed ID: 18202964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study.
    Tan D; Haines CJ; Limpaphayom KK; Holinka CF; Ausmanas MK
    Maturitas; 2005 Sep; 52(1):35-51. PubMed ID: 16211697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
    Wolfe BM; Koval JJ; Nisker JA
    Am J Obstet Gynecol; 1998 Apr; 178(4):787-92. PubMed ID: 9579445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Haines CJ; Xing SM; Park KH; Holinka CF; Ausmanas MK
    Maturitas; 2005; 52(3-4):264-76. PubMed ID: 15921865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
    Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
    Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
    Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    Climacteric; 1999 Sep; 2(3):181-8. PubMed ID: 11910595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen.
    Wakatsuki A; Sagara Y
    Maturitas; 1996 Aug; 25(1):35-44. PubMed ID: 8887307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of postmenopausal hormone therapy every day and every other day on lipid levels according to difference in body mass index.
    Yasui T; Umino Y; Takikawa M; Uemura H; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Menopause; 2005 Mar; 12(2):223-31. PubMed ID: 15772571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do lipid profiles of postmenopausal women under oral hormone replacement therapy remain stable or reveal a multiphasic course in time?
    Alper T; Cetinkaya MB; Kokcu A; Yanik FF; Malatyalioglu E
    Gynecol Endocrinol; 2004 Apr; 18(4):199-205. PubMed ID: 15293891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased activity of lecithin:cholesterol acyltransferase during short-term oral estrogen progestin replacement therapy in a group of postmenopausal women.
    Ulloa N; Verdugo C; Rios M; Sepúlveda J; Sepúlveda S; Naveas R; Calvo C
    Metabolism; 1998 Mar; 47(3):297-300. PubMed ID: 9500566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
    Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
    Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.